Janux Therapeutics, Inc. (JANX)
15.04
-0.20
(-1.31%)
USD |
NASDAQ |
Apr 15, 16:00
14.91
-0.13
(-0.86%)
After-Hours: 06:18
Janux Therapeutics Research and Development Expense (Quarterly) : 31.55M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 2.561B |
| EyePoint Plc | 59.21M |
| CorMedix, Inc. | 8.60M |
| ADMA Biologics, Inc. | 1.376M |
| Viking Therapeutics, Inc. | 153.46M |